Interindividual variation in cardiometabolic health outcomes following 6-months of endurance training in youth at risk of Type 2 Diabetes Mellitus.

Author(s):  
Travis J. Hrubeniuk ◽  
Jacqueline L. Hay ◽  
Andrea C. MacIntosh ◽  
Brandy Wicklow ◽  
Kristy Wittmeier ◽  
...  

This study determined the interindividual variation in the cardiometabolic response to 6-months of moderate or vigorous intensity exercise training (ET) among youth at risk for type 2 diabetes mellitus. Youth were randomized to moderate intensity ET (45-55% heart rate reserve; n= 31), vigorous intensity ET (70-85% heart rate reserve; n= 37), or control (n= 36). Only those attending ≥70% of ET sessions were included. Cardiometabolic measures included insulin sensitivity, hepatic triglyceride content, visceral adipose area, and cardiorespiratory fitness. The contribution of ET to interindividual variation was determined using the standard deviation of individual responses (SDIR) and considered meaningful if the SDIR surpassed the smallest worthwhile difference (SWD), calculated as 0.2 * the standard deviation of the control group baseline values. ET meaningfully contributed to the interindividual variation among changes in VO2peak following moderate (SDIR: 2.04) and vigorous (SDIR: 3.43) ET (SWD: 1.17 ml•kg-FFM-1•min-1), body fat percentage and hepatic triglyceride content following moderate-intensity ET (SDIR: 1.64, SWD: 1.05%; SDIR: 10.08, SWD: 1.06%, respectively), and visceral fat mass following vigorous ET (SDIR: 11.06, SWD: 7.13 cm2). Variation in the changes in insulin sensitivity were not influenced by ET. The contribution of ET to interindividual variation appears to be influenced by the desired outcome and prescribed intensity. Trial Registration: Database: ClinicalTrials.gov. Identifier: NCT00755547. Novelty Bullets: - The contribution of exercise to interindividual variation following training depends on the outcome and exercise intensity. - Increasing exercise intensity does not systematically reduce non-response among youth at risk for type 2 diabetes.

Diabetes ◽  
2019 ◽  
Vol 68 (Supplement 1) ◽  
pp. 2397-PUB
Author(s):  
HALA K. EL MIKATI ◽  
JULIE PIKE ◽  
KATIE HABERLIN-PITTZ ◽  
LISA YAZEL-SMITH ◽  
BRETT M. MCKINNEY ◽  
...  

2022 ◽  
Author(s):  
Janiel L. Pimentel ◽  
Kiley B. Vander Wyst ◽  
Erica G. Soltero ◽  
Armando Peña ◽  
Houchun H. Hu ◽  
...  

2014 ◽  
Vol 99 (4) ◽  
pp. 804-812 ◽  
Author(s):  
R. C. Mollard ◽  
M. Senechal ◽  
A. C. MacIntosh ◽  
J. Hay ◽  
B. A. Wicklow ◽  
...  

Diabetes Care ◽  
2010 ◽  
Vol 34 (1) ◽  
pp. 193-197 ◽  
Author(s):  
M. G. Holl ◽  
S. S. Jaser ◽  
J. A. Womack ◽  
V. L. Jefferson ◽  
M. Grey

Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 1643-P
Author(s):  
BABAK MOKHLESI ◽  
KARLA A. TEMPLE ◽  
ASHLEY N. HOGAN ◽  
SHARON EDELSTEIN ◽  
KRISTEN J. NADEAU ◽  
...  

2009 ◽  
Vol 79 (6) ◽  
pp. 286-292 ◽  
Author(s):  
Sarah S. Jaser ◽  
Marita G. Holl ◽  
Vanessa Jefferson ◽  
Margaret Grey

2011 ◽  
Vol 25 (3) ◽  
pp. 153-161 ◽  
Author(s):  
Vanessa Jefferson ◽  
Sarah S. Jaser ◽  
Evie Lindemann ◽  
Pamela Galasso ◽  
Alison Beale ◽  
...  

2015 ◽  
Vol 64 (1) ◽  
pp. 63-68 ◽  
Author(s):  
Fernando Bril ◽  
Sushma Kadiyala ◽  
Paola Portillo Sanchez ◽  
Nishanth E Sunny ◽  
Diane Biernacki ◽  
...  

The underlying mechanisms responsible for the development and progression of non-alcoholic fatty liver disease (NAFLD) in patients with type 2 diabetes mellitus (T2DM) are unclear. Since the thyroid hormone regulates mitochondrial function in the liver, we designed this study in order to establish the association between plasma free T4 levels and hepatic triglyceride accumulation and histological severity of liver disease in patients with T2DM and NAFLD. This is a cross-sectional study including a total of 232 patients with T2DM. All patients underwent a liver MR spectroscopy (1H-MRS) to quantify hepatic triglyceride content, and an oral glucose tolerance test to estimate insulin resistance. A liver biopsy was performed in patients with a diagnosis of NAFLD. Patients were divided into 5 groups according to plasma free T4 quintiles. We observed that decreasing free T4 levels were associated with an increasing prevalence of NAFLD (from 55% if free T4≥1.18 ng/dL to 80% if free T4<0.80 ng/dL, p=0.016), and higher hepatic triglyceride accumulation by 1H-MRS (p<0.001). However, lower plasma free T4 levels were not significantly associated with more insulin resistance or more severe liver histology (ie, inflammation, ballooning, or fibrosis). Decreasing levels of plasma free T4 are associated with a higher prevalence of NAFLD and increasing levels of hepatic triglyceride content in patients with T2DM. These results suggest that thyroid hormone may play a role in the regulation of hepatic steatosis and support the notion that hypothyroidism may be associated with NAFLD. No NCT number required.


2019 ◽  
Vol 20 (8) ◽  
pp. 1056-1063 ◽  
Author(s):  
Babak Mokhlesi ◽  
Karla A. Temple ◽  
Ashley H. Tjaden ◽  
Sharon L. Edelstein ◽  
Kristen J. Nadeau ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document